Cargando…

Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis

Hepatitis C virus (HCV) affects over 180 million people worldwide and it's the leading cause of chronic liver diseases and hepatocellular carcinoma. HCV is classified into seven major genotypes and a series of subtypes. In general, HCV genotype 4 (HCV-4) is common in the Middle East and Africa,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd Elrazek, Abd Elrazek, Bilasy, Shymaa E., Elbanna, Abduh E. M., Elsherif, Abd Elhalim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603091/
https://www.ncbi.nlm.nih.gov/pubmed/25526438
http://dx.doi.org/10.1097/MD.0000000000000204
_version_ 1782394861083688960
author Abd Elrazek, Abd Elrazek
Bilasy, Shymaa E.
Elbanna, Abduh E. M.
Elsherif, Abd Elhalim A.
author_facet Abd Elrazek, Abd Elrazek
Bilasy, Shymaa E.
Elbanna, Abduh E. M.
Elsherif, Abd Elhalim A.
author_sort Abd Elrazek, Abd Elrazek
collection PubMed
description Hepatitis C virus (HCV) affects over 180 million people worldwide and it's the leading cause of chronic liver diseases and hepatocellular carcinoma. HCV is classified into seven major genotypes and a series of subtypes. In general, HCV genotype 4 (HCV-4) is common in the Middle East and Africa, where it is responsible for more than 80% of HCV infections. Although HCV-4 is the cause of approximately 20% of the 180 million cases of chronic hepatitis C worldwide, it has not been a major subject of research yet. The aim of the current study is to survey the morbidities and disease complications among Egyptian population infected with HCV-4 using data mining advanced computing methods mainly and other complementary statistical analysis. Six thousand six hundred sixty subjects, aged between 17 and 58 years old, from different Egyptian Governorates were screened for HCV infection by ELISA and qualitative PCR. HCV-positive patients were further investigated for the incidence of liver cirrhosis and esophageal varices. Obtained data were analyzed by data mining approach. Among 6660 subjects enrolled in this survey, 1018 patients (15.28%) were HCV-positive. Proportion of infected-males was significantly higher than females; 61.6% versus 38.4% (P = 0.0052). Around two-third of infected-patients (635/1018; 62.4%) were presented with liver cirrhosis. Additionally, approximately half of the cirrhotic patients (301/635; 47.4%) showed degrees of large esophageal varices (LEVs), with higher variceal grade observed in males. Age for esophageal variceal development was 47 ± 1. Data mining analysis yielded esophageal wall thickness (>6.5 mm), determined by conventional U/S, as the only independent predictor for esophageal varices. This study emphasizes the high prevalence of HCV infection among Egyptian population, in particular among males. Egyptians with HCV-4 infection are at a higher risk to develop cirrhotic liver and esophageal varices. Data mining, a new analytic technique in medical field, shed light in this study on the clinical importance of esophageal wall thickness as a useful predictor for risky esophageal varices using decision tree algorithm.
format Online
Article
Text
id pubmed-4603091
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46030912015-10-27 Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis Abd Elrazek, Abd Elrazek Bilasy, Shymaa E. Elbanna, Abduh E. M. Elsherif, Abd Elhalim A. Medicine (Baltimore) 4500 Hepatitis C virus (HCV) affects over 180 million people worldwide and it's the leading cause of chronic liver diseases and hepatocellular carcinoma. HCV is classified into seven major genotypes and a series of subtypes. In general, HCV genotype 4 (HCV-4) is common in the Middle East and Africa, where it is responsible for more than 80% of HCV infections. Although HCV-4 is the cause of approximately 20% of the 180 million cases of chronic hepatitis C worldwide, it has not been a major subject of research yet. The aim of the current study is to survey the morbidities and disease complications among Egyptian population infected with HCV-4 using data mining advanced computing methods mainly and other complementary statistical analysis. Six thousand six hundred sixty subjects, aged between 17 and 58 years old, from different Egyptian Governorates were screened for HCV infection by ELISA and qualitative PCR. HCV-positive patients were further investigated for the incidence of liver cirrhosis and esophageal varices. Obtained data were analyzed by data mining approach. Among 6660 subjects enrolled in this survey, 1018 patients (15.28%) were HCV-positive. Proportion of infected-males was significantly higher than females; 61.6% versus 38.4% (P = 0.0052). Around two-third of infected-patients (635/1018; 62.4%) were presented with liver cirrhosis. Additionally, approximately half of the cirrhotic patients (301/635; 47.4%) showed degrees of large esophageal varices (LEVs), with higher variceal grade observed in males. Age for esophageal variceal development was 47 ± 1. Data mining analysis yielded esophageal wall thickness (>6.5 mm), determined by conventional U/S, as the only independent predictor for esophageal varices. This study emphasizes the high prevalence of HCV infection among Egyptian population, in particular among males. Egyptians with HCV-4 infection are at a higher risk to develop cirrhotic liver and esophageal varices. Data mining, a new analytic technique in medical field, shed light in this study on the clinical importance of esophageal wall thickness as a useful predictor for risky esophageal varices using decision tree algorithm. Wolters Kluwer Health 2014-12-02 /pmc/articles/PMC4603091/ /pubmed/25526438 http://dx.doi.org/10.1097/MD.0000000000000204 Text en © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 4500
Abd Elrazek, Abd Elrazek
Bilasy, Shymaa E.
Elbanna, Abduh E. M.
Elsherif, Abd Elhalim A.
Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis
title Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis
title_full Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis
title_fullStr Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis
title_full_unstemmed Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis
title_short Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis
title_sort prior to the oral therapy, what do we know about hcv-4 in egypt: a randomized survey of prevalence and risks using data mining computed analysis
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603091/
https://www.ncbi.nlm.nih.gov/pubmed/25526438
http://dx.doi.org/10.1097/MD.0000000000000204
work_keys_str_mv AT abdelrazekabdelrazek priortotheoraltherapywhatdoweknowabouthcv4inegyptarandomizedsurveyofprevalenceandrisksusingdataminingcomputedanalysis
AT bilasyshymaae priortotheoraltherapywhatdoweknowabouthcv4inegyptarandomizedsurveyofprevalenceandrisksusingdataminingcomputedanalysis
AT elbannaabduhem priortotheoraltherapywhatdoweknowabouthcv4inegyptarandomizedsurveyofprevalenceandrisksusingdataminingcomputedanalysis
AT elsherifabdelhalima priortotheoraltherapywhatdoweknowabouthcv4inegyptarandomizedsurveyofprevalenceandrisksusingdataminingcomputedanalysis